title: Scleromyxedema, a therapeutic dilemma.
abstract: Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.
authors: Basic Science, School of Medicine, Universidad de Monterrey, Nuevo León, Mexico, USA.
authors: Julio Cesar
authors: JC
authors: Salas-Alanis
authors: Department of Dermatology, University Hospital "Dr. Jose E. González", Universidad Autonoma de Nuevo Leon, Nuevo León, Mexico, USA.
authors: Brayant
authors: B
authors: Martinez-Jaramillo
authors: Department of Dermatology, University Hospital "Dr. Jose E. González", Universidad Autonoma de Nuevo Leon, Nuevo León, Mexico, USA.
authors: Minerva
authors: M
authors: Gomez-Flores
authors: Department of Dermatology, University Hospital "Dr. Jose E. González", Universidad Autonoma de Nuevo Leon, Nuevo León, Mexico, USA.
authors: Jorge
authors: J
authors: Ocampo-Candiani
keywords: Papular mucinosis; UVA1; scleromyxedema; thalidomide; treatment failure